Drug companies spent over £7.5m on joint working in 2016-17, but 1 in 5 NHS trusts are keeping details secret. This goes against official guidance that urges openness and transparency
Roche and Halozyme are at it again—12 years after their initial collaboration around the latter’s Enhanze drug delivery platform, Roche is licensing it again, this time...